š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The aim of this study is to evaluate the safety and immunogenicity of Fluzo...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01946425
The aim of the study was to assess the immunogenicity and safety of Fluzone...
Status
Completed
Location
Sanofi Pasteur Investigational Site 002
Start Date
2015-06-17
Trial ID
NCT03546192
Treatments Being Tested
The ability of the vaccines today to generate a long-lasting protection aga...
Status
Recruiting
Location
Emory University Hospital
Start Date
2023-04-11
Trial ID
NCT05801978
Treatments Being Tested
The aim of the study is to evaluate the safety and immunogenicity of the 20...
Status
Completed
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02563093
The primary objective of the study was to provide sera (collected from part...
Status
Completed
Location
Investigational Site Number 8400002
Start Date
2019-09-30
Trial ID
NCT04109222
The aim of the study was to generate immunogenicity and safety data in the ...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-27
Trial ID
NCT02451358
Treatments Being Tested
The aim of the study was to describe the safety and immunogenicity of the 2...
Status
Completed
Location
Multiple Locations
Start Date
2016-09-15
Trial ID
NCT02908269
Primary Objective: To provide serum samples (collected from participants b...
Status
Completed
Location
Investigational Site Number 8400001
Start Date
2020-09-16
Trial ID
NCT04551677
The study will evaluate the safety and immunogenicity of the 2014-2015 form...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02222870